Quantcast

Posts related to ‘DNA’

Genentech Masks a Whiff (DNA)

Posted: July 14, 2008 at 3:12 pm

Genentech Inc. (NYSE: DNA) is initially looking like a severe disappointment to those who thought Cramer's call last week was the right one.  The largest biotech in the U.S. posted ...
Read Full Story »

Genentech Ready to Lead Biotech Earnings Bias (DNA, BIIB)

Posted: July 14, 2008 at 12:37 pm

Genentech Inc. (NYSE: DNA) is set to report earnings after the close of trading today.  The largest biotech in the U.S. is expected to post $0.86 EPS on $3.23 Billion ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (AIG, BARE, CWST, DNA, GILD, MHS, SLAB, TKLC, UBS, WCA)

Posted: June 19, 2008 at 6:11 am

These are ten of the analyst calls we are seeing early this Thursday morning in early bird pre-market trading hours:American International Group (NYSE: AIG) raised to Buy at Citigroup.Bare Escentuals ...
Read Full Story »

Select Positive ASCO Data (ARRY, AZN, LLY, DNA, GSK, ONXX, PFE, ZGEN)

Posted: May 16, 2008 at 7:26 am

Last night was a novel release from the American Society of Clinical Oncology (or ASCO) as the society decided to publish all of the findings to the public at once.  ...
Read Full Story »

Genentech & Biogen-Idec Tank Rituxan Hopes on Lupus Treatment (DNA, BIIB)

Posted: April 29, 2008 at 8:29 am

Genentech, Inc. (NYSE:DNA) and Biogen Idec, Inc. (Nasdaq:BIIB) came out this morning with some disappointing news.  The biotech giants have announced that a Phase II/III study of Rituxan for lupus ...
Read Full Story »

Biotech Business Daily (AMLN, CERS, LLY, DNA, GTOP, IMCL)

Posted: April 21, 2008 at 11:54 am

Amylin Pharmaceuticals (NASDAQ: AMLN) reported first quarter losses of $68.8 million, or $0.51 EPS, wider than the $49.4 million in the first quarter of 2007. Losses are credited to a ...
Read Full Story »

Genentech Expands Stock Buybacks (DNA)

Posted: April 15, 2008 at 3:12 pm

Genentech, Inc. (NYSE:DNA) has announced that the biotech giant has authorized the extension of its current stock repurchase program through June 30, 2009 and it amended the current repurchase program.It ...
Read Full Story »

Media Digest 4/11/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Posted: April 11, 2008 at 2:52 am

According to Reuters, Bernanke says that the current financial system can be fixed. Reuters writes that Google (GOOG) is using Frank Quattrone as its investment bank advisor.Reuters reports that banks ...
Read Full Story »

Genentech Shares Hang In Despite Soft Key Drug Sales (DNA)

Posted: April 10, 2008 at 3:31 pm

Shares of Genentech Inc. (NYSE: DNA) are trading slightly lower after reporting a gain in earnings.  The biotech giant posted $0.74 net EPS, but non-GAAP EPS excluding special items was ...
Read Full Story »

Genentech to Set Biotech Tone For Earnings Season (DNA, OSIP, SGEN, ABT, BIIB)

Posted: April 7, 2008 at 3:45 pm

Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are $0.82 EPS on $3.11 billion in revenues.  Next quarter estimates ...
Read Full Story »

Biotech Movers & Shakers (AMGN, CRME, DNDN, GNVC, DNA, QLTI, TBRN, BBH, XBI)

Posted: March 17, 2008 at 12:30 pm

Biotech’s are sliding along with all the others today. A look at the highlights and outliers:Amgen (NASDAQ: AMGN) and Wyeth (NYSE: WYE) announced that arthritis and psoriasis drug Enbrel will ...
Read Full Story »

Cramer Hunts For Safe Harbor in a Storm: Genentech (DNA, GILD)

Posted: March 10, 2008 at 7:44 pm

On tonight's Mad Money on CNBC, Jim Cramer said he's officially going "cautious" and noted that you can't just start recommending stocks in the current market.  He noted that we ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (AVR, DNA, GM, HAIN, JNPR, MTL, MOT, NYT, BTU, YUM)

Posted: February 25, 2008 at 7:44 am

Below are the top research calls that 247WallSt.com is focusing on: Aventine Renewable Energy (NYSE: AVR) downgraded to Sell from Hold at Soleil.Genentech (NYSE: DNA) raised to Outperform at Rodman ...
Read Full Story »

Medical Concern About FDA Approval Of Genentech (DNA) Avastin

Posted: February 24, 2008 at 1:26 pm

The FDA has approved Genentech's (NYSE: DNA) drug Avastin for the treatment of breast cancer. The product is already Genentech's top selling drug but is marketed for treating other cancers.Tests ...
Read Full Story »

Media Digest 2/20/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Posted: February 20, 2008 at 4:04 am

According to Reuters, ING took a Q4 impairment at the low end of expectations.Reuters writes that KKR Financial Holdings has delayed debt payments on loans backed by mortgge-related securities.Reuters writes ...
Read Full Story »